CEM Receives Fourth Patent on Microwave Peptide Synthesis
September 9, 2009
MATTHEWS, N.C. -- CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its fourth US patent covering microwave-assisted peptide synthesis (US 7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all [...]
Seahorse Bioscience in Collaboration with University of Nebraska
September 9, 2009
Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference - New instrument reveals the impact of genetic and nutrient factors in the malignant transformation of cancer cells. NORTH BILLERICA, Mass., Sept. 9 -- Seahorse Bioscience, Inc., the leader in the design and development of [...]
QIAGEN Releases New Pandemic Influenza A/H1N1 Detection Kit
September 9, 2009
New Test Complements Company’s Broad Menu of Solutions for Surveillance of Swine Flu Infections used by Health Authorities Worldwide VENLO, The Netherlands & DALIAN, China--QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), today announced both the launch of a new Influenza A/H1N1 test and several updates to its activities in providing solutions for the global surveillance [...]
Complete Genomics Demonstrates Its Technology’s Potential
September 9, 2009
Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers - Its High-Quality, Low-Cost Human Genome Sequencing Technology is Helping to Further Cancer, Metabolic and Neurologic Disease Research MOUNTAIN VIEW, Calif.--Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to [...]
Agilent Technologies Prices $750 Million of Senior Notes
September 9, 2009
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE: A - News) today announced the pricing of two series of its senior notes in an aggregate principal amount of $750 million, in an underwritten, registered public offering. Of these notes, $500 million will mature in September 2015 and will bear interest at an annual rate of 5.50 percent, [...]
Advion BioServices Expands LC/MS Biomarker Group
September 9, 2009
Enables Customers to Streamline Drug Discovery and Development Costs Ithaca, NY - Advion BioServices, Inc., a leading contract research organization serving pharmaceutical and biotechnology partners worldwide, today announced the expansion of its existing LC/MS Biomarker Services Group. The expansion comes in response to increased interest from leading pharmaceutical companies in the use of biomarkers as [...]
New England Peptide Opens Office in San Francisco Bay
September 9, 2009
Peptide Veteran Phipps Takes Point for Hands-on Service to West Coast Clients New England Peptide has opened an office in San Francisco Bay to provide better service to clients on the West Coast. The office will be run by John Phipps, a leading peptide chemist and entrepreneur who founded Global Peptide Services. NEP is the [...]
Universal Detection Technology Awarded U.S. Army Contract
September 9, 2009
Universal Detection Technology Awarded U.S. Army Contract for Detection of Anthrax, Ricin and Other Biological Weapons - Contract from Military Intelligence Unit to Cover Anthrax, Ricin, Botulinum LOS ANGELES--Universal Detection Technology (www.udetection.com)(OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today [...]
Enzo Biochem Appoints Dr. Mohan Chellani
September 8, 2009
Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs NEW YORK--Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Mohan Chellani, Ph.D., formerly a senior manager with Quest Diagnostics, as Vice President of Scientific Affairs at its Enzo Clinical Labs subsidiary. He will oversee all aspects [...]
PerkinElmer Acquires Leading Diagnostics Company in China
September 8, 2009
Global leader in human and environmental health secures Shanghai instrument provider SYM-BIO Lifescience as part of efforts to expand regional and worldwide diagnostics offerings WALTHAM, Mass. & SHANGHAI--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced it has completed the acquisition of Shanghai-based [...]

